N1 Overview
N1 is an early-stage venture capital firm established in 2019, managing $60 million across two funds focused on AI and healthcare. With offices in Prague and San Francisco, N1 invests in pre-seed and seed-stage companies, offering initial investments ranging from $100,000 to $1 million. The firm emphasizes supporting founders from the early stages to global impact, providing capital, experience, and access across Europe and the US. N1's portfolio spans Europe and the US, united by a global intent, and includes companies like Myriad AI, TrueClaim, and Scalpel AI. The team comprises partners with experience in building and scaling companies, aiming to help founders build globally from day zero.
Is N1 the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with N1, along with a list of other relevant VCs, is available on Hopohopo.io.
N1
Investment focus
Investment role
Lead and follow
Stages
Pre-seed, Seed
First ticket size
US$100,000 - US$1,000,000
Contact information
Founder & Managing Director
Marek Moravec
How to approach funds like N1
When reaching out to N1, founders should highlight their ambition to scale internationally and demonstrate a clear path to global relevance, especially in AI or healthcare. N1 values founders who can articulate how their technology or solution addresses a significant market need and who show readiness to leverage cross-continental networks. Emphasize your team's technical depth and your vision for building a category-defining company, as N1 is drawn to founders with both domain expertise and the drive to lead in competitive markets.
Find the best-fitting investors for your startup
Stop wasting weeks searching for the right investors. Upload your deck and get matched with investors who actually fit your startup — so you can focus on building, not chasing.
